Kathryn E Wengel Johnson & Johnson (JNJ) insider trading activity

Kathryn E Wengel is EVP, Chief TO and Risk Officer of JOHNSON & JOHNSON. Currently has a direct ownership of 90,836 shares of JNJ, which is worth approximately $14.7 Million. The most recent transaction as insider was on Feb 15, 2022, when has been sold 10,386 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 90.8K

10.42% 3M change

10.42% 12M change

Total Value Held $14.7 Million

Kathryn E Wengel Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 15 2022	BUY Exercise of conversion of derivative security	-	10,386 Added 12.02%	76,009 Common Stock
Feb 14 2022	SELL Payment of exercise price or tax liability	$117,351 $168.85 p/Share	695 Reduced 1.05%	65,623 Common Stock
Feb 14 2022	BUY Exercise of conversion of derivative security	-	1,896 Added 2.78%	66,318 Common Stock
Feb 12 2021	SELL Payment of exercise price or tax liability	$730,738 $165.55 p/Share	4,414 Reduced 6.41%	64,422 Common Stock
Feb 12 2021	BUY Exercise of conversion of derivative security	-	10,362 Added 13.08%	68,836 Common Stock
Sep 02 2020	SELL Open market or private sale	$2,473,975 $153.52 p/Share	16,115 Reduced 21.62%	58,419 Common Stock
Sep 02 2020	BUY Exercise of conversion of derivative security	$1,027,976 $63.79 p/Share	16,115 Added 17.78%	74,534 Common Stock
Feb 13 2020	SELL Payment of exercise price or tax liability	$1,070,072 $150.46 p/Share	7,112 Reduced 10.85%	58,419 Common Stock
Feb 13 2020	BUY Exercise of conversion of derivative security	-	15,809 Added 19.44%	65,531 Common Stock
Dec 12 2019	SELL Open market or private sale	$284,538 $141.07 p/Share	2,017 Reduced 3.9%	49,719 Common Stock
Dec 12 2019	BUY Exercise of conversion of derivative security	$126,305 $62.62 p/Share	2,017 Added 3.75%	51,736 Common Stock
Feb 11 2019	SELL Payment of exercise price or tax liability	$533,961 $131.94 p/Share	4,047 Reduced 8.87%	41,600 Common Stock
Feb 11 2019	BUY Grant, award, or other acquisition	-	1,102 Added 2.36%	45,647 Common Stock
Feb 11 2019	BUY Exercise of conversion of derivative security	-	6,722 Added 13.11%	44,545 Common Stock
Feb 08 2019	SELL Payment of exercise price or tax liability	$313,236 $132.0 p/Share	2,373 Reduced 5.9%	37,823 Common Stock
Feb 08 2019	BUY Exercise of conversion of derivative security	-	5,882 Added 12.77%	40,196 Common Stock

Also insider at

LABORATORY CORP OF AMERICA HOLDINGS Healthcare

Director

KEW

Kathryn E Wengel

EVP, Chief TO and Risk Officer

New Brunswick, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JNJ shares.

Notify only if

Value

Insider Trading

Get notified when an Johnson & Johnson insider buys or sells JNJ shares.

Notify only if

Operation

Value

Type

News

Receive news related to JOHNSON & JOHNSON

Track Activities on JNJ

Account